Human prothrombin complex(Sinopharm Guizhou Plasma)

人凝血酶原复合物（国药贵州血液）

Report date: 2026/01/07 09:20:35

Base Information

Drug NameHuman prothrombin complex(Sinopharm Guizhou Plasma)
Drug Alias Name人凝血酶原复合物
ClassificationBiologics > Blood components
Mechanisms of ActionCoagulation factor VII modulatorsCoagulation factor X modulatorsCoagulation factor IX modulators +[4] 
TargetsCoagulation factor VIICoagulation factor XCoagulation factor IX +[4] 
Therapy Area/IndicationsHemorrhageHemophilia B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesSinopharm Group Guizhou Bio-pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinopharm Guizhou Blood Products Co LtdSinopharm Group Guizhou Bio-pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHemorrhageHemophilia B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A